Harmony Biosciences Holdings Overview
Harmony Biosciences Holdings Target Price
Analysts' 12-month price predictions for HRMY.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.26
Average Target Price
$36.00
3.4% downside
3.4% downside1 analysts in the last 4 months
High: $36 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-30 | Deutsche BankDavid Hoang | $36 | 3.4% downside |  |
| 2026-02-23 | Deutsche Bank | $31 | 16.8% downside | |
| 2026-02-19 | Mizuho Securities | $50 |  34.2% upside | |
| 2026-02-11 | UBSYoun Shim | $46 | 23.5% upside | |
| 2026-01-08 | Truist Financial | $45 | 20.8% upside | |
| 2025-12-01 | Mizuho Securities | $46 | 23.5% upside | |
| 2025-11-24 | OppenheimerAndreas Argyrides | $62 | 66.4% upside | |
| 2025-10-29 | Mizuho Securities | $36 | 3.4% downside | |
| 2025-10-15 | UBS | $43 | 15.4% upside | |
| 2025-09-25 | H.C. Wainwright | $55 | 47.6% upside | |
| 2025-07-10 | Goldman SachsCorinne Johnson | $33 | 11.4% downside | |
| 2025-04-28 | UBS | $48 | 28.8% upside | |
| 2024-10-30 | Goldman SachsCorinne Jenkins | $28 | 24.9% downside | |
| 2024-10-10 | Mizuho SecuritiesGraig Suvannavejh | $52 | 39.6% upside | |
| 2024-09-10 | UBSAshwani Verma | $56 | 50.3% upside | |
| 2024-08-08 | Mizuho SecuritiesGraig Suvannavejh | $42 | 12.7% upside | |
| 2024-06-24 | OppenheimerFrancois Brisebois | $56 | 50.3% upside | |
| 2024-05-01 | NeedhamAmi Fadia | $52 | 39.6% upside | |
| 2024-04-30 | Raymond JamesDanielle Brill | $37 | 0.7% downside | |
| 2022-10-14 | JefferiesChris Howerton | $61 | 63.7% upside | |